The latest closing stock price for CytomX Therapeutics as of November 20, 2024 is 0.87.
An investor who bought $1,000 worth of CytomX Therapeutics stock at the IPO in 2015 would have $-933 today, roughly -1 times their original investment - a -25.89% compound annual growth rate over 9 years.
The all-time high CytomX Therapeutics stock closing price was 34.22 on March 12, 2018.
The CytomX Therapeutics 52-week high stock price is 5.85, which is 572.4% above the current share price.
The CytomX Therapeutics 52-week low stock price is 0.83, which is 4.6% below the current share price.
The average CytomX Therapeutics stock price for the last 52 weeks is 1.58.
An investor who bought $1,000 worth of CytomX Therapeutics stock at the IPO in 2015 would have $-933 today, roughly -1 times their original investment - a -25.89% compound annual growth rate over 9 years.
The all-time high CytomX Therapeutics stock closing price was 34.22 on March 12, 2018.
The CytomX Therapeutics 52-week high stock price is 5.85, which is 572.4% above the current share price.
The CytomX Therapeutics 52-week low stock price is 0.83, which is 4.6% below the current share price.
The average CytomX Therapeutics stock price for the last 52 weeks is 1.58.